AFP Clinical Answers
Aspirin for CVD, Scabies, Intimate Partner Violence, Maternal Vaccines, Caregiver Burden
Am Fam Physician. 2019 Nov 15;100(10):606.
Is low-dose aspirin effective for the primary prevention of CVD in moderate-risk patients?
After five years of treatment in a randomized controlled trial, patients at moderate risk of heart disease who took low-dose aspirin did not show a decrease in coronary events or all-cause mortality and had slightly more gastrointestinal bleeding. Using aspirin for the primary prevention of cardiovascular disease (CVD) is not a one-size-fits-all proposition. We need to risk-stratify patients according to benefits and harms and engage in shared decision-making with each patient.
What is the first-line treatment for scabies?
Permethrin 5% cream (Elimite) is the first-line treatment for scabies. Physicians should educate their patients about correct application of permethrin cream, reminding them that it should be applied to all areas of the body from the neck down, remain on the skin for eight to 14 hours or overnight, washed off, and reapplied in one week. Patients should be told that they may continue to itch for up to two weeks, even after appropriate and effective treatment.
Who should be screened for intimate partner violence (IPV), and what screening tools are recommended?
The U.S. Preventive Services Task Force recommends that clinicians screen for IPV in women of reproductive age and provide or refer women who screen positive to ongoing support services. Several screening instruments can be used to screen women for IPV. The following instruments accurately detect IPV in the past year among adult women: Humiliation, Afraid, Rape, Kick (HARK); Hurt, Insult, Threaten, Scream (HITS); Extended–Hurt, Insult, Threaten, Scream (E-HITS); Partner Violence Screen (PVS); and Woman Abuse Screening Tool (WAST).
How effective is prenatal maternal vaccination in preventing pertussis in infants?
Women should receive the tetanus toxoid, reduced diphtheria toxoid,
Copyright © 2019 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions